The implementation of disease control programmes (CPs) provides benefits for animals, farmers, the industry and consumers, because they increase animal health and welfare and decrease antibiotic use. Control programmes reduce direct disease losses (e.g. by decreasing the number of diseased animals and increasing production performance) and indirect disease losses (e.g. consequences of trade constraints).

The European Union (EU) has an active animal health policy and supports Member States (MS) to eradicate, control and monitor notifiable diseases. For cattle diseases that are regulated at the EU level, often input-based requirements for the disease-free status of the animal, herd and/or country are defined. Examples of input-based standards are for example the level of testing e.g. animals or herds, the matrix in which the test has to be performed e.g. blood, saliva, milk, etc. and application of defined control measures on the expectation that an adequate output will be achieved.

For cattle diseases with little or no EU regulations (termed non-regulated diseases in the remainder of this paper), country specific national or regional surveillance programmes have been implemented in many countries throughout Europe. Examples include bovine viral diarrhoea (BVD), infectious bovine rhinotracheitis (IBR), paratuberculosis, *Mycoplasma bovis* and salmonellosis ([@bib0020]). The heterogeneity in disease CPs and the lack of agreed upon methodologies to assess and compare health status at the herd, region and country level under such programmes, impairs the comparison of the confidence of freedom from disease of cattle between countries. Given that the different CPs are tailored to the specific country needs, it is undesirable for these diseases to move to input based standards. There is a need for the development of transparent methods that enable comparison of different CPs based on factors such as freedom from infection but also cost-effectiveness and social acceptance of these programmes ([@bib0020]).

Output-based standards prescribe what the surveillance must achieve in contrast to what surveillance activities must be performed as in input-based surveillance. Output-based approaches can achieve harmonized surveillance outputs that are comparable between countries. Recently, output-based approaches have been adopted internationally by the OIE and in the new EU Animal Health Law, with increased recognition of the value of risk-based sampling for demonstration of disease-free status ([@bib0030]; [@bib0015]). Currently there is an EU funded study in progress that aims to develop an output-based model for comparison of freedom from BVD-infection ([@bib0045], [@bib0050]). Additionally, the merit of output-based surveillance was already studied for different infections ([@bib0015]; [@bib0035]; [@bib0025]). When correctly implemented, output-based methods can result in disease CPs tailored for each individual country based on their context risk (i.e. herd density, contact structure and disease prevalence) resulting in optimally designed, cost-effective and socially accepted CPs ([@bib0030]; [@bib0015]). Consequently, output-based control has the potential to enhance the safety of animal trade, while allowing countries to decide which control measures are most suitable for their epidemiological situation ([@bib0020]).

A research grant was received from the European Cooperation in Science and Technology (COST, [www.COST.EU](http://www.COST.EU){#intr0005}) that provided the opportunity to work on the topic of output based surveillance and to achieve mutual goals with a wide variety of scientists, stakeholders, policy makers and other relevant professionals from different countries ([@bib0005]). COST is an organization funded by the European Union Horizon 2020 framework that provides funding for researchers and innovators to set up interdisciplinary research networks.

SOUND Control -- COST Action is a project of 4 years (Start date: 29/10/2018; End date: 28/10/2022) and at this moment only WG 1 and 2 already had results that are officially delivered and thus are ready to be presented.

In this COST Action SOUND control, more than 100 (multidisciplinary) researchers from different fields (veterinarians, epidemiologists, economists, statisticians, sociologists) from 32 countries work together to stimulate initiatives towards the development of a widely adaptable output-based framework to substantiate the confidence of freedom and cost-effectiveness in current CPs for non-EU regulated cattle diseases ([@bib0005]).

The work in this Action was divided into five different working groups each with representatives from multiple countries. In the first Working Group (WG1) current control efforts were described for non-regulated cattle diseases within the participating countries. We started with evaluating and mapping CPs for all non-EU regulated cattle diseases ([@bib0010]). In order to be concise, definitions for were discussed and set. First a definition of 'non-regulated' cattle disease was discussed and it was agreed that all cattle diseases not listed as A or B category disease in the upcoming new Animal Health Law ([@bib0040], [@bib0040]) were included in this COST Action. We further discussed classifications of disease statuses (i.e. officially free, perceived free, sporadic cases and endemic) and when a country could claim that a CP was in place (i.e. official documentation and implementation on regional or national level).

The first analysis of the data that was subsequently delivered by each of the participating countries reveals that among the countries included, 25 different non-EU regulated cattle diseases are controlled in one or more participating countries ([@bib0010]). On average, there are eight CPs in place per country (minimum of 1 to maximum of 20) and the distribution per country is shown in [Fig. 1](#fig0005){ref-type="fig"} . The number of CPs in place per disease are listed in [Table 1](#tbl0005){ref-type="table"} ([@bib0010]). Note that some countries have only regional CPs in place for certain diseases. Based on this information, the next step is to obtain more detailed information about the different country specific CPs, to create a complete overview of the control efforts per disease. The most controlled diseases within the 32 countries that participate in this COST Action, "top 10 disease", are listed in [Table 1](#tbl0005){ref-type="table"} ([@bib0010]). The preliminary results from WG1 demonstrate that most of the participating countries have a CP for Enzootic Bovine Leukosis, Infectious Bovine Rhinotracheitis, Bovine Viral Diarrhoea, Bluetongue, Paratuberculosis, Bovine Genital Campylobacteriosis, Anthrax and Trichomonosis. Other diseases are controlled only by a few or even by just a single country. Turkey is the country that controls the greatest number of diseases, 20. Sweden tops the list of countries that have a free status for diseases, with an official or perceived[1](#fn0005){ref-type="fn"} free status for 13 diseases ([@bib0010]). Another task for WG1 was to identify and reach an agreement on the scientific and practical requirements that should be met by a framework that aims at an objective comparison of the output of CPs for cattle diseases. At this stage of the project the biggest challenge is to make this framework applicable to all countries in Europe, while acknowledging the large diversity in the cattle sector structure, in risk factor occurrence and in data access and quality.Fig. 1Number of non-EU regulated control programmes implemented by country part of SOUND-Control COST Action.Fig. 1Table 1List of cattle diseases and countries with control programmes (CPs) in place for each disease in 29 European countries that submitted information to SOUND Control in 2019.Table 1DiseasesNumber of countries that have CPs in place for the diseaseEnzootic Bovine Leukosis (EBL)25Bluetongue24Infectious Bovine Rhinotracheitis (IBR)23Bovine Viral Diarrhoea (BVD)22Paratuberculosis16Anthrax15Bovine Genital Campylobacteriosis13Trichomonosis11Salmonella9Neosporosis7Epizootic Haemorrhagic Disease7Leptospirosis6Aujeszky's Disease6*Mycoplasma bovis*5*Mycoplasma mycoides*5*Streptococcus agalactiae*5Q-fever5Bovine Coronavirus4*Staphylococcus aureus*4Bovine Respiratory Syncytial Virus3*Trichophyton verrucosum*3Bovine digital dermatitis2Liver fluke2Surra2

Evaluation of the availability and quality of quantitative data that is needed for an output-based framework is being conducted by Working Group 2 (WG2). First, all parameters needed to proof freedom from disease were determined for three example diseases (BVDV, BHV1, and Paratuberculosis). A data-collection tool was prepared based on previous developed tools in RISKSUR ([@bib0035]) and STOC free ([@bib0045]). The first draft was tested by contrasting data of two fairly different countries, Albania and the Netherlands ([Table 2](#tbl0010){ref-type="table"} ). The results were discussed during a workshop with the whole consortium and, based on feedback, a final version is currently under development. During the project this data-collection tool will be completed for the countries in the consortium, resulting in basic sets of input values of each of the COST countries that can be used in the output-based framework.Table 2A selection of data obtained for the comparison of control programs for cattle diseases in the Netherlands and Albania in 2019.Table 2ParameterThe NetherlandsAlbaniaCattle densityHighLowHerd size (\# of cattle over 1 yr old)Medium to large: average 130 cows.Small: average 2 cows, 73 % herds less than 5 cows.Available dataMany data routinely collected in official census databases.There is an official database: few parameters available.Disease introduction riskMany contacts between herds, movement control incorporated in CPs, many imports.Many contacts between herds, no strict animal movement control program in place.Control programmes in placeMany (12): some compulsory (initiated by sector), some voluntaryNo compulsory CP, 3 voluntary CPsHerd biosecurity levelNo representative and recent data available.No representative and recent data available

Working Group 3 (WG3) tasks include the evaluation of the most suitable mathematical or statistical methods for objective and standardized comparison of freedom from disease and the identification of any gaps. Within the consortium, knowledge on several statistical methods such as scenario tree modelling, Bayesian latent class models, Bayesian networks and artificial intelligence are evaluated for advantages and disadvantages in their applicability to compare CPs for freedom from disease.

Working Group 4 (WG4) is developing a research agenda to encourage researchers to solve methodological and other problems that may hinder the development, implementation, acceptance and use of output-based methods. Working Group 4 will identify mathematical, epidemiological, economic and social gaps from a variety of sources including the other WGs in the project. WG4 has adopted a participatory approach that will include surveillance and disease control experts in government and academia along with representatives from farmer and industry groups. The Working Group held a first facilitated workshop to identify information needs from output-based CPs to facilitate trade. The workshop included academic, government and industry surveillance and disease control experts. We plan to use questionnaires, in person and online workshops, and interviews with other stakeholders to explore the full range of information and other gaps that will need to be addressed before output-based CPs are accepted by all stakeholders.

The full output of this Action is communicated with the scientific community and national stakeholders by means of a specific Working Group (WG5), using several communication tools including a dedicated website ([www.sound-control.eu](http://www.sound-control.eu){#intr0010}). The knowledge that will be achieved during the SOUND control Action will be disseminated and incorporation of an output-based framework is encouraged both at national and European level.

At the end of this project, the team will be one step closer to the development of an output-based framework that enables standardized comparison of outputs of heterogeneous disease CPs. In combination with the results of a partner project, STOC free ([@bib0045]) in which an output-based framework to determine freedom from disease is being developed, the fundamentals are laid to move towards increased application of output-based systems. Although the primary focus of this Action concerns non-harmonized disease CPs, outcomes of this project will also be applicable for EU regulated diseases, which are currently mostly sustained by input-based standards. The developed framework should be adaptable not only to multiple diseases but also to different animal species. Projects such as SOUND control aim to move towards a single general regulatory output-based framework that is applicable for comparison of freedom from disease, is cost-effective and is socially acceptable among different countries.
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The perceived free status was defined as: a country can provide evidence that there is absence from infection. There is however, no officially recognized free status by the EU.
